This website tells you more about Creon and
Pancreatic Exocrine Insufficiency
Availability of Creon (Pancreatin) 40,000
Mylan, the marketing authorization holder for Creon in the UK, is currently experiencing temporary supply constraints of Creon 40K.
Latest Supply Status
We are currently experiencing a reduced supply of Creon 40K and anticipate this to be an ongoing issue. We expect a small amount of stock to be available over the coming months but the reduced quantities are lower than the market demand.
With patient access as our priority, we will continue to proactively and diligently update pharmacies, healthcare professionals and patient advocacy groups across the country regarding any changes in stock availability.
At this time, there are no supply constraints of Creon Micro, Creon 10K and Creon 25K.
Ongoing Supply Management
Mylan is working diligently to manage supply and expediting where possible to alleviate the situation and achieve a steady state of Creon 40K supply as expeditiously as possible.
Information for Patients and Prescribers
Mylan is unable to make any specific treatment recommendations to healthcare professionals or for individual patients, however, it is recommended that patients affected by this should speak to their treating physician to discuss treatment options according to their health needs and their relevant clinical history.
During this period of supply constraint, healthcare professionals may wish to consider the temporary option of prescribing the required dose in Creon 25K, if this is appropriate for the individual patient.
Creon is a Pancreatic Enzyme Replacement Therapy (PERT) that helps patients with Pancreatic Exocrine Insufficiency (PEI) to break down food and digest nutrients by replacing the pancreatic enzymes made by a healthy pancreas. The active substance of Creon is pancreatin, a natural substance from the pancreas of the pig; as a biologic product Creon is produced using a complex manufacturing process that is subject to high standards and strict requirements in terms of quality and compliance.
If you require additional information or have any questions, please contact +44(0) 1707 853 100.
CRE-2018-0148 DOP: July 2018
Please select from below depending on whether you are
a Creon patient, or a UK Healthcare Professional
This website is intended for use by UK Healthcare Professionals and patients who have been prescribed Creon